Total Voting Rights

RNS Number : 6319T
Hutchison China Meditech Limited
31 March 2016
 

 

 

 

 

 

Total Voting Rights

 

 

London: Thursday, March 31, 2016: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at March 31, 2016, the issued share capital of Chi-Med consisted of 60,283,118 ordinary shares of US$1.00 each, with each share carrying one right to vote and with no shares held in treasury.

 

The above figure of 60,283,118 may be used by shareholders as the denominator for the calculations by which they could determine if they are required to notify their interest in, or a change to their interest in, Chi-Med under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

 

 

Ends

 

 

Contact

 

Investor Enquiries

 

Christian Hogg, CEO

+852 2121 8200

 

 

International Media Enquiries

 

Anthony Carlisle, Citigate Dewe Rogerson

+44 7973 611 888 (Mobile)

 

 

US Based Media Enquiries

 

Brad Miles, BMC Communications

+1 (917) 570 7340

Susan Duffy, BMC Communications

+1 (917) 499 8887

 

 

Investor Relations

 

Jillian Connell, The Trout Group

+1 (646) 378 2956

David Dible, Citigate Dewe Rogerson

+44 20 7638 9571
+44 7967 566 919 (Mobile)

 

 

Panmure Gordon (UK) Limited

 

Richard Gray / Andrew Potts

+44 (20) 7886 2500

 

 

Notes to Editors

 

About Chi-Med

 

Chi-Med is a China-based, globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products.  Its Innovation Platform focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market.  Its Commercial Platform manufactures, markets and distributes prescription drugs and consumer health products in China.

 

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001).  For more information, please visit: www.chi-med.com.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREALDFDLFKEEF
UK 100

Latest directors dealings